scispace - formally typeset
F

Fatemeh Atyabi

Researcher at Tehran University of Medical Sciences

Publications -  340
Citations -  12766

Fatemeh Atyabi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Drug delivery & PLGA. The author has an hindex of 53, co-authored 310 publications receiving 9985 citations. Previous affiliations of Fatemeh Atyabi include University of Manchester & University of Tehran.

Papers
More filters
Journal ArticleDOI

Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents

TL;DR: Increasing experience in the field of preparation, characterization, and in vivo application of PLGA nanoparticles has provided the necessary momentum for promising future use of these agents in cancer treatment, with higher efficacy and fewer side effects.
Journal ArticleDOI

Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method

TL;DR: This paper summarizes the development of a nanoparticulate system based on ionic gelation between chitosan and gum Arabic for oral delivery of insulin, and suggests that release is possibly controlled by diffusion or relaxation of the polymer chains.
Journal ArticleDOI

Silk fibroin nanoparticle as a novel drug delivery system.

TL;DR: In this paper, a review of Silk Fibroin (SF) based drug delivery systems is presented, where Silk fibroin is a naturally occurring protein polymer with several unique properties that make it suitable material for incorporation into a variety of drug delivery vehicles capable of delivering a range of therapeutic agents.
Journal ArticleDOI

Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax

TL;DR: High drug entrapment efficiency of 97% revealed the ability of SLNs to incorporate a poorly water-soluble drug such as ketoprofen and stability of nanoparticles with negligible drug leakage after 45 days of storage was indicated.
Journal ArticleDOI

Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate

TL;DR: FOL-targeted DTX NPs showed a greater extent of intracellular uptake in FOL-receptor-positive cancer cells (SKOV3) in comparison with the non- targeted NPs, indicating that the F OL-recept-mediated endocytosis mechanism could have a role in the cellular uptake of NPs.